Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer

2008

Background The main objective of this study was to evaluate the safety of second-line pemetrexed in Stage IIIB or IV NSCLC.

Keywords:

References

Citations